Description
A cutting-edge investigational peptide that functions as a triple
agonist of GLP-1, GIP, and glucagon receptors, making it one of the most promising
therapies for significant and sustained fat loss. Unlike older GLP-1 agonists like
semaglutide, it activates additional pathways that not only suppress appetite
and improve insulin sensitivity but also increase energy expenditure and fat oxidation.
Clinical trials have shown dramatic weight loss results—up to 24% body weight
reduction in some participants—along with improvements in blood glucose control, lipid
metabolism, and liver fat reduction. Its broad metabolic effects make it a powerful tool for
tackling obesity and related metabolic diseases.
Reviews
There are no reviews yet.